Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
about
Capecitabine in the management of colorectal cancerThymidine Phosphorylase in Cancer; Enemy or Friend?Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesisA phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancerCapecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialCapecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study.Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane.Encapsulation of poorly soluble drugs in polymer-drug conjugates: effect of dual-drug nanoformulations on cancer therapy.Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer.Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trialPhase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysisRole of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells.Heterogeneous nuclear ribonucleoprotein H1/H2-dependent unsplicing of thymidine phosphorylase results in anticancer drug resistanceClinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials.A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignanciesA long-term survivor of repeated inguinal nodes recurrence of papillary serous adenocarcinoma of CUP: case report.Paclitaxel, Epirubicin and Capecitabine (TEX) as First-Line Treatment for Metastatic Breast Cancer: a Pilot Phase I/II Feasibility StudyAnticancer activity of a thymidine quinoxaline conjugate is modulated by cytosolic thymidine pathwaysThymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancerPhase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation.Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study.A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC).A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer.Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial.The potential for oral combination chemotherapy of 5'-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancerTrimodality therapy for stage II-III carcinoma of the esophagus: a dose-ranging study of concurrent capecitabine, docetaxel, and thoracic radiotherapy.Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancerA phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancerPhase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancerPhase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer.XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer.Drug resistance and the role of combination chemotherapy in improving patient outcomes.
P2860
Q24633039-03133080-A72F-4D30-9CD5-AAB3412667E4Q26795650-E4022174-F9AA-4F8C-9D1D-38C84D38E7CEQ28345390-8B4A59E9-1984-40BD-ADB0-86C3F0D6E9D6Q33180637-7A4BAA6B-059E-4CD4-9AE0-DF6AC73B1E76Q33354817-D6CF027A-DCA9-473E-81FE-91E3CC01DEC8Q33361603-CA7BCEE6-1898-46CA-B4EF-6ACB3EB311DFQ33377361-F77FD34B-03FB-4965-B3BB-4874F872A59CQ33426732-662D20AD-69E6-4AAD-8D30-65F5B9C6F571Q33631745-E8E696BC-56F5-4420-9C0C-ACF8D8FCA1E8Q33686380-7E71E7AA-E4AD-4188-85A3-810AF619AD7EQ33778285-FF8585BE-E5AC-4D40-A739-41FF15955463Q33821528-8CAD01AF-933C-4756-ABAF-1F046139ED61Q34010159-AE5D56DA-D929-4163-B738-285E82ADE69EQ34187204-EBC92B71-031F-4355-9228-D832A5B48D36Q34333852-01F86F6D-3EA5-4E78-9C32-16BCF6F76D90Q34536974-0F7A8542-3CA9-4E6C-B1A4-A8795B021B45Q34542467-65BD8CE3-D7A1-40E0-9581-AB9DFED83166Q34665196-F68002A7-EBC9-47A6-BD60-D559AAD0F454Q35046452-03977161-BDEF-4BE9-9A59-0ED2BC485D14Q35180995-7E1DC644-9051-4617-BB2F-05C3139D7D41Q35219161-B44B5B8C-3854-4DBF-A7B7-2E3100FC85D4Q35588620-4B8959A5-4980-46DD-B269-5A5C13A4A79EQ35776220-F6E731B5-A126-482C-BBAD-D9CEC1F43BE7Q35849214-B3CAC2C5-9C50-4A41-931B-5ECF827F6FECQ35872701-FE9925F6-694B-436F-9B28-977A3A53B2E4Q35948050-8F5AE924-5C55-414E-B75F-69A6E3DBDA9DQ35995493-91B5B1C1-3D56-472D-A206-AB407CD29EC9Q36070770-B6720D8A-B405-44E4-97E5-66C5BFC6FBE5Q36547234-65DB7734-F39F-40B0-B6A9-363514D772C4Q36614734-724B3D44-3233-4DDA-B46A-5CEDE3A7BB65Q36615283-2EB91782-F957-4509-B5A7-C9FB53DFE38FQ36616002-DAE36D49-C061-45F6-B535-C87053770922Q36671460-46262525-7D85-483D-AADB-A76DC75FC136Q36691859-C73EDBF1-1DA1-4886-82CA-1917560C897EQ36694314-8CC12B1E-20B9-4A3A-A08B-B8E68B3C2146Q36694899-D4067122-A2E5-451A-B886-A1BF9E4F658DQ36695635-524E2666-692B-4A11-8F98-98D96CF07ED4Q36697132-E38ADC83-7178-4164-800B-E3DAC43B9477Q36969180-2C67493B-9073-4945-8706-C7ABEF6C521AQ36999509-962C1A5B-8FDB-48C8-A5E6-7CC8861D65C3
P2860
Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Induction of thymidine phospho ...... re in human cancer xenografts.
@ast
Induction of thymidine phospho ...... re in human cancer xenografts.
@en
Induction of thymidine phospho ...... re in human cancer xenografts.
@nl
type
label
Induction of thymidine phospho ...... re in human cancer xenografts.
@ast
Induction of thymidine phospho ...... re in human cancer xenografts.
@en
Induction of thymidine phospho ...... re in human cancer xenografts.
@nl
prefLabel
Induction of thymidine phospho ...... re in human cancer xenografts.
@ast
Induction of thymidine phospho ...... re in human cancer xenografts.
@en
Induction of thymidine phospho ...... re in human cancer xenografts.
@nl
P2093
P1476
Induction of thymidine phospho ...... ere in human cancer xenografts
@en
P2093
P304
P407
P577
1998-04-01T00:00:00Z